• The University of Western Australia (M504), 35 Stirling Highway,

    6009 Perth

    Australia

  • 1175 Citations
  • 18 h-Index
20072022
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Cheah is a Consultant Haematologist at Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine WA and Hollywood Private Hospital. He received his MBBS from the University of Western Australia in 2003 and completed post-graduate training in Clinical and Laboratory Haematology in Perth (Fremantle Hospital) and Melbourne. He completed a Translational Research Fellowship at Peter MacCallum Cancer Centre (Melbourne, Australia) and an Advanced Lymphoma Fellowship at MD Anderson Cancer Center (Houston, Texas, USA).

Dr Cheah is the clinical lead for lymphoma at Sir Charles Gairdner Hospital, Director of the WA Lymphoma Centre of Research Excellence and Director of the Lymphoma Fellowship Program. His research interests are novel drug therapies and prevention of CNS relapse in lymphomas. He has authored >60 peer-reviewed publications, 6 book chapters, attracted >2.5 million dollars in competitive grant funding and reviews for major journals in the field. He was awarded Cancer Council WA Early Career Cancer Researcher of the Year in 2018 and is an internationally recognised lymphoma researcher. 

He is passionate about improving access for Australian patients to the novel lymphoma treatments and training the next generation of lymphoma researchers. He delights in his young family and enjoys running and cycling in his spare time.

Roles and responsibilities

Dr Cheah is a Clinical Haematologist with subspecialty expertise is in the management of lymphoma. He teaches Haematology at an undergraduate and post-graduate level through UWA and Sir Charles Gairdner Hospital.

He provides inpatient and outpatient care to patients through the Haematology Department at Sir Charles Gairdner Hospital and Hollywood Private Hospitals; as a pathologist he provides laboratory diagnostic services through Pathwest Laboratory Medicine WA. 

Future research

Developing an early phase clinical trials program exploring novel agents in patients with lymphoma.

Funding overview

AI, NHMRC project grant, 2013. "Phase I study of oral NMP in relapsed/refractory multiple myeloma." PI: Professor David Ritchie, Royal Melbourne Hospital.

 

NHMRC project grant 2018 APP 1142980

Title: Integrating immunity and genetics in Follicular Lymphoma to establish a prognostic score fit for the modern era

CIA: Maher Gandhi, CIG Chan Cheah

Value: $1,377,173

Medical Research Future Fund 2017 LCTRC APP 1152436

Title:An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies

CIA: Maher Gandhi, CIB Chan Cheah

Value: $1,586,476

 

Cancer Council WA collaborative cancer grant scheme 2017

Title: Designing better cellular and targeted therapies for lymphoma and leukaemia.

CIA: Bree Foley, CIC:Chan Cheah

Value: $50,000

Previous positions

Translational Research Fellow, Peter MacCallum Cancer Centre (Melbourne, Australia)
Lymphoma Fellow, MD Anderson Cancer Center (Houston, Texas, USA).

Industrial relevance

Principal investigator on numerous industry sponsored and academic cooperative group clinical trials.

Teaching overview

Lectures in Haematology in various units at UWA. Medical student supervisor through inpatient and outpatient clinics at Sir Charles Gairdner Hospital. 

Director of Fellowship Program at Sir Charles Gairdner Hospital / Blood Cancer Research WA.

Research

Dr Cheah performs clinical research focused on improving outcomes for patients with lymphoma.

Education/Academic qualification

Medicine, Doctor of Medical Science, University of Melbourne

Medicine, MBBS, The University of Western Australia

Keywords

  • Drug Discovery
  • Medicine and Pharma
  • Biotechnology
  • lymphoma

Fingerprint Dive into the research topics where Chan Cheah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma

Ng, Z. Y., Bishton, M., Ritchie, D., Campbell, R., Gilbertson, M., Hill, K., Ratnasingam, S., Schwarer, A., Manos, K., Shorten, S., Ng, M., Nelson, N., Xin, L., Widanalage, S. D. M., Sunny, T., Purtill, D., Poon, M., Johnston, A., Cochrane, T., Lee, H-P. & 6 othersHapgood, G., Tam, C., Opat, S., Hawkes, E., Seymour, J. & Cheah, C. Y., Aug 2019, In : Hematological Oncology. 37, 3, p. 253-260 8 p.

Research output: Contribution to journalArticle

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Barraclough, A., Alzahrani, M., Ettrup, M. S., Bishton, M., van Vliet, C., Farinha, P., Gould, C., Birch, S., Sehn, L. H., Sovani, V., Ward, M. S., Augustson, B., Biccler, J., Connors, J. M., Scott, D. W., Gandhi, M. K., Savage, K. J., El-Galaly, T., Villa, D. & Cheah, C. Y., 9 Jul 2019, In : Blood advances. 3, 13, p. 2013-2021 9 p.

Research output: Contribution to journalArticle

Designing optimal prognostic models for diffuse large B-cell lymphoma

Keane, C. & Cheah, C. Y., 11 Apr 2019, In : LEUKEMIA & LYMPHOMA. 3 p.

Research output: Contribution to journalEditorial

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma

Pinnix, C. C., Milgrom, S. A., Cheah, C. Y., Gunther, J. R., Ludmir, E. B., Wogan, C. F., Nastoupil, L. J., Neelapu, S. S., Westin, J., Lee, H. J., Iyer, S. P., Steiner, R. E., Fayad, L. E., Fowler, N. H., Wang, M. L., Samaniego, F., Rodriguez, M. A., Rich, A. E., Medeiros, L. J. & Dabaja, B. S., 14 May 2019, In : Blood advances. 3, 9, p. 1356-1367 12 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

Chin, C. K., Tsang, E., Mediwake, H., Khair, W., Biccler, J., Hapgood, G., Mollee, P., Nizich, Z., Joske, D., Radeski, D., Cull, G., Villa, D., El-Galaly, T. C. & Cheah, C. Y., 1 Mar 2019, In : British Journal of Haematology. 184, 5, p. 826-828 3 p.

Research output: Contribution to journalLetter

Projects 2018 2022